Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
A sea turtle resembling something out of a sci-fi horror film was rescued along the Texas coast this weekend after washing ashore sick and heavily encrusted with marine life. Early Saturday morning, ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
"We are hopeful for her recuperation and eventual release back into the Gulf," officials said Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been working at PEOPLE since 2024, and ...
It started with the mysterious discovery of more than a hundred turtles, some with their shells smashed, others dismembered, all of them dead. It ended with a potential warning for the future. It was ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results